Transitional change in the clinical features of pulmonary tuberculosis

Respiration

Volumn 75, Issue 3, 2008, Pages 304-309

  Kobashi, Yoshihiro ^a   Mouri, Keiji ^a   Fukuda, Minoru ^a   Yoshida, Kouichiro ^a   Miyashita, Naoyuki ^a   Oka, Mikio ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Immunosuppressive patients; Pulmonary tuberculosis; Transitional change

Indexed keywords

CORTICOSTEROID; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL FEATURE; COLLAGEN DISEASE; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROGNOSIS; SPUTUM SMEAR; STATISTICAL ANALYSIS; THORAX RADIOGRAPHY;

AGED; BRONCHOSCOPY; COMORBIDITY; FEMALE; HUMANS; JAPAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 41349086642     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101438     Document Type: Article

References (15)

1. Ohmori M, Ishikawa N, Yoshiyama T, et al: Current epidemiological trend of tuberculosis in Japan. Int J Tuberc Lung Dis 2002;6:415-423.
2. Guzman CP, Cruz AT, Velarde HV, et al: Progressive age-related changes in pulmonary tuberculosis images and the effect of diabetes. Am J Respir Crit Care Med 2000;162:1728-1740.
3. Ikezoe J, Takeuchi N, Johkoh M, et al: CT appearance of pulmonary tuberculosis in diabetes and immunocompromised patients: comparison with patients who had no underlying disease. Am J Roentogenol 1992;159:1175-1179.
4. Nemery B, Yew WW, Albent R, et al: Tuberculosis, nontuberculous lung infection, pleural disorders, pulmonary function, respiratory muscles, occupational lung disease, pulmonary infections, and social issues in AJRCCM in 2004. Am J Respir Crit Care Med 2005;171:554-562.
5. Segerra F, Sherman DS, Aguero J, et al: Lower lung field tuberculosis. Chest 1974;65:522-526.
6. Toyota T: Studies on the changes in clinical features of tuberculosis (in Japanese, abstract in English). Kekkaku 1990;65:619-631.
7. Schitrit D, Vertenshtein T, Shitrit AB, et al: The role of routine culture for tuberculosis lung during bronchoscopy in a nonendemic area: analysis of 300 cases and review of the literature. Am J Infect Control 2005;33:602-605.
8. Tueller C, Chhajed PN, Buitrago-Tellez C, et al: Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis. Eur Respir J 2005;20:767-772.
9. Reisner D: Pulmonary tuberculosis of the lower lobe. Arch Intern Med 1935;56:258-280.
10. Miyazaki N, Matsuzaki Y, Ninomiya K, et al: Lower lung field tuberculosis (in Japanese, abstract in English). Kekkaku 1993;68:589-596.
11. Pratt-Johnson JH: Observations on lower lobe tuberculosis. Br J Dis Chest 1959;53:385-389.
12. Palmer PES: Pulmonary tuberculosis - usual and unusual radiographic presentations. Semin Roentogenol 1979;14:204-243.
13. Keane J, Gershon S, Wise RP, et al: Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-1104.
14. Mutlu GM, Mutlu EA, Mellmeyer A, et al: Pulmonary adverse events of anti-tumor necrosis factor-α antibody therapy. Am J Med 2006;119:639-646.
15. Hirano K, Kazumi Y, Abe C, et al: Resistance to antituberculous drugs in Japan. Tuber Lung Dis 1996;77:130-135.